Sign in

Lost your password?
(close)

Japan

Japan / Enhancing Patient Engagement in Clinical Trials

Writing in the July issue of DIA’s Global Forum magazine Pfizer R&D Japan’s Atsushi Kitamura examines how both pharmaceutical companies and patients in Japan can help increase patient engagement in…

USA / Impact of COVID-19 on US Clinical Studies Conducted by Japan-Based Pharmaceutical Companies

Writing in the June edition of DIA’s Global Forum magazine, representatives of Japanese pharmaceutical companies…

Takeda / Pivoting to Growth Amid Renewed Focus on “Core Assets”

“This marks a significant moment in Takeda’s history and is an exciting step forward as we accelerate our…

APAC / Self-Medication in the Age of COVID: The Country-Specific Role & Acceptability of OTC Medicines

Writing in the May edition of DIA’s Global Forum magazine, Toshiyoshi Tominaga of the Asia-Pacific…

In Conversation

Enhancing Patient Engagement in Clinical Trials in Japan

Writing in the July issue of DIA’s Global Forum magazine Pfizer R&D Japan’s Atsushi Kitamura examines how both pharmaceutical companies and patients in Japan can help increase patient engagement in the clinical trial process.   Patient engagement in clinical trials in Japan has been progressing steadily in the last few years. Pharmaceutical companies and patients who have not realized its…

Enhancing Patient Engagement in Clinical Trials in Japan

Enhancing Patient Engagement in Clinical Trials in Japan

Japan / Taiho Pharmaceutical: An Oral Chemotherapy Pioneer

Japanese pharma companies are already far lower-profile than their occidental counterparts but an even lesser-known…

Japan / Life Science VC Funding: Signs of Growth & Untapped Opportunities

Toshio Fujimoto, MD, MBA, the General Manager of Shonan Health Innovation Park examines why Japan – despite being…

Japan / Enhancing Patient Engagement in Clinical Trials

Writing in the July issue of DIA’s Global Forum magazine Pfizer R&D Japan’s Atsushi Kitamura examines how…

Japan / Eisai Targeting Global Leadership in Neurology & Oncology Niches

Founded by Toyoji Naito in December 1941, in just under 80 years, Eisai has become a leading global biopharma…

We use cookies to ensure that we give you the best experience on our site. For more info click here